Faldaprevir for the Treatment of Hepatitis C

The current treatments for chronic hepatitis C virus (HCV) genotype 1 infection are combinations of direct-acting antivirals, and faldaprevir is one of the new generation of HCV NS3/4A protease inhibitors. At the end of 2013, the US Food and Drug Administration (FDA) approved the HCV NS3/4A protease...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Tatsuo, Yokosuka, Osamu, Omata, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394460/
https://www.ncbi.nlm.nih.gov/pubmed/25749475
http://dx.doi.org/10.3390/ijms16034985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394460/
https://www.ncbi.nlm.nih.gov/pubmed/25749475
http://dx.doi.org/10.3390/ijms16034985

Ejemplares similares